Home > Boards > US OTC > Medical - Equipment >

Viking Systems Inc (VKNG)

VKNG RSS Feed
Add VKNG Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator
Search This Board:
Last Post: 5/28/2013 5:07:37 PM - Followers: 91 - Board type: Free - Posts Today: 0

 

http://www.vikingsystems.com/

 

·  Viking Systems, Inc. is a designer, manufacturer and marketer of FDA-cleared, CE-marked, high-performance laparoscopic vision systems.   
 
·  Intellectual property consists of 25 exclusive US & International patents.  
 
 

 

(Click on link below to view videos on NBC, Fox, Australia News, & More.)

http://www.vikingsystems.com/video/default.html

 

 

Viking Systems, Inc. (VKNG.OB) is a publicly owned designer, manufacturer and marketer of high-performance laparoscopic vision systems. The Company's flagship product is the 3Di Vision System, an advanced three-dimensional (3D) vision system used by surgeons for minimally invasive surgery (MIS). For the first time, surgeons are now offered 3D visualization, voice-activated access to clinical information and complete freedom of movement during MIS.  These features enable surgeons to perform complex MIS procedures more confidently, allowing more patients to realize the benefits of minimally invasive techniques. 

 

Viking also manufactures advanced two-dimensional (2D) vision systems for targeted configurations and channels, as well as 2D cameras and components, sold through strategic partner and OEM programs. 

 


 

 

 

The Company is currently developing a portfolio of targeted technologies and services that serve the current and emerging needs of the minimally invasive surgical network.  Viking's mission is to deliver visualization, integrated information and control solutions to the surgical team, enhancing their performance in MIS and complex surgical procedures.

 

 


 

 

Share Structure Per 10-K filed 22 Feb 2010:

http://yahoo.brand.edgar-online.com/displayfilinginfo.aspx?FilingID=7070912-826-229844&type=sect&dcn=0001019687-10-000737

Authorized Shares (AS) = 400,000,000 Shares
Outstanding Shares (OS) = 
 57,989,090 Shares (as of 10/04/2010)
Restricted Shares = 36,033,138 Shares
Float = 9,323,627 Shares

There are no Preferred Shares issued. 
 

 


 
VKNG Partners
 

http://www.intuitivesurgical.com/

http://agreements.realdealdocs.com/License-Agreement/EXCLUSIVE-LICENSE-AGREEMENT-2117080/

(Click on link above for full read.)

 

http://www.intuitivesurgical.com/index.aspx

http://www.viddler.com/explore/intusurg/videos/35/2.559

 

 

Intuitive Surgical, Inc. trades on the NASDAQ at over $293.00+ per share under the ticker of ISRG:

http://finance.yahoo.com/q/pr?s=ISRG

 

 

http://www.bostonscientific.com/

 

Boston Scientific Corporation trades on the NYSE at over $5.00+ per share under the ticker of BSX:

http://finance.yahoo.com/q/pr?s=BSX

 

Viking Systems and Boston Scientific Extend Supply Contract Through May 2012

http://finance.yahoo.com/news/Viking-Systems-and-Boston-pz-4035167801.html?x=0&.v=1

 

http://www.medtronic.com/

 

Medtronic trades on the NYSE at over $34.00+ per share under the ticker of MDT:

http://finance.yahoo.com/q/pr?s=MDT

 

 

 

http://www.richardwolfusa.com/

 

 

http://www.biomet.com/

 

 

http://www.bbraunusa.com/

 


 

VKNG Distributor
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

 
VKNG Products
 
 

 
 

  
 

 
 

 
VKNG DD Posts
 

  
VKNG SEC Filings
Bullets from recent Annual Report:

-As of December 31, 2008, we believe more than 100 of our proprietary visualization systems were in service worldwide.  Moreover, we have sold more than 1,300 2D digital cameras to ODM/OEM partners, including Boston Scientific Corporation (“Boston Scientific”) and Medtronic, Inc. (“Medtronic”).   Our ODM products are jointly designed with our partners to meet their exact specifications for their particular market.

-The ODM/OEM business has provided us with a recurring source of revenue and has been a source of growth. We are the strategic visualization supplier and partner for several leading procedure-specific medical device manufacturers such as B. Braun, Richard Wolf, Boston Scientific, Medtronic and Biomet, Inc. We have sold over four thousand 2D digital cameras, accessories and unique visualization solutions to our ODM/OEM partners, and in 2007 and 2008 ODM/OEM sales accounted for approximately $5,235,000 and $5,137,000 in revenue, respectively.

-Although competition exists for aspects of our visualization product line, we believe that no single company offers a complete and independent 3D visualization and information solution specifically directed at complex minimally invasive procedures. In addition, we are not aware of any other true 3D PHD that has been cleared for marketing in surgical applications by the FDA.

-A separate high end segment of the visualization technology market is fully immersive 3D-vision-enabled robotics, in particular Intuitive Surgical’s daVinci System, which generally sells for up to $1,500,000 per system and requires disposables that cost the hospital up to an estimated $1,500 to $3,000 per procedure.  We do not compete in this segment. Although the robotic technologies provided by companies such as Intuitive Surgical, Inc., with its proprietary da Vinci system, incorporate 3D vision capabilities into their systems, our products are not in direct competition with these products. Rather, our strategy is to offer standalone 3D vision capability at a base price of $100,000 to $150,000. 


 

VKNG News

http://www.vikingsystems.com/overview/news/default.html

 


 

VKNG Management

http://www.vikingsystems.com/overview/people/executive-management/default.html

 

William C. Bopp
Mr. William C. Bopp was appointed Chief Executive Officer of Viking Systems, Inc. effective January 4, 2008. Prior to joining Viking, Mr. Bopp was a private investor.  Previously he was with ALARIS Medical Systems, Inc., a developer, manufacturer and marketer of infusion devices and related disposable products, where he had been senior vice president and chief financial officer.  Mr. Bopp joined ALARIS in March 1999, as vice president and chief financial officer.  He was elected to the position of senior vice president and chief financial officer in November 1999.  ALARIS was acquired for approximately $2.0 billion by Cardinal Health, Inc. in July 2004, and Mr. Bopp assisted for an additional year with the integration of ALARIS into Cardinal Health before retiring in 2005.  Mr. Bopp was formerly executive vice president and chief financial officer of C.R. Bard, Inc.   Since 1980, he held positions of increasing responsibility with Bard, currently a $2.0 billion developer, manufacturer and marketer of health care products.  From 1995 through 1998, he also served as a member of the Board of Directors of Bard and a member of the Finance Committee of the Board.  Mr. Bopp is a graduate of Harvard College, Cambridge, MA, and completed his MBA, Finance, from the Harvard Business School.

 

 

John “Jed” Kennedy
Mr. Kennedy is the president and chief operating officer of Viking Systems. Mr. Kennedy joined Vista Medical in January 1997 as vice president of research and development.  He was appointed vice president/general manager of Westborough operations in January 2000 before being appointed executive vice president and COO in December 2000.  Prior to joining Vista, Mr. Kennedy held various positions in manufacturing, quality engineering and product development at Smith & Nephew Endoscopy from 1984 through January 1997.  From 1996 through January 1997 he was the group director of product development responsible for managing all divisional product development activities.  From 1993 through 1996, Mr. Kennedy was director, research and development responsible for the management of four technology product development groups.  Prior to 1984, he held various engineering positions at Honeywell’s Electro-Optics and Avionics divisions. Mr. Kennedy received a B.S. in Manufacturing Engineering from Boston University in 1979.

 

 

Robert Mathews
Prior to joining the Viking Systems’ team as the Chief Financial Officer, he was senior vice president and chief financial officer at Cardinal Health’s Clinical Technologies and Services (CTS) segment, where he was responsible for the Global Finance function across all of CTS businesses. At its formation, CTS had annual revenues of approximately $2.5 billion and approximately 8,000 employees. Before joining Cardinal Health, Mr. Mathews was with Alaris Medical Systems. Mr. Mathews, then vice president of finance, chief accounting officer, and executive committee member, was responsible for developing, implementing and managing the operational and financial strategy of Alaris. During his tenure, Mathews helped lead a successful and comprehensive strategy that would result in significant shareholder value improvement, and ultimately the successful sale of Alaris to Cardinal Health for $2 billion in an all cash transaction. Mr. Mathews, who began his career at PriceWaterhouse, earned his Bachelor of Science degree from San Diego State University where he majored in business administration with an emphasis in accounting.

 

Board of Directors
William C. Bopp
Director, Chairman of the Board
 
John ”Jed” Kennedy
Director, President and Chief Operating Officer
 
William T. Tumber
Director
 

 
VKNG Contact Info

Viking Systems, Inc.
134 Flanders Road
Westborough, MA 01581
Phone: 508-366-8882
Fax: 508-366-8858
Web Site:
http://www.vikingsystems.com
 

VKNG Transfer Agent

Fidelity Transfer Company

1800 South West Temple

Suite 301

Salt Lake City, UT 84115

801-466-7208

 

 

 

Daily View

 

Weekly View

 

 

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
VKNG
Current Price
Volume:
Bid Ask Day's Range
Wiki
PostSubject
#4104   whats your assessment? buccaneer1961 05/28/13 05:07:36 PM
#4103   We just recieved our NOTICE OF MERGER AND [SMART MONEY] 10/16/12 07:37:08 AM
#4102   VKNG: Viking Systems, Inc. merged into Arrow Merger Renee 10/05/12 09:16:42 AM
#4101   You should see your shares disappear and the junkHustler 09/28/12 01:55:32 PM
#4100   I didn't sell. What happens now? lostinvestor 09/28/12 01:51:40 PM
#4099   VKNG: Renee 09/27/12 05:05:27 PM
#4098   If the merger goes through and we havent lostinvestor 09/25/12 02:47:04 PM
#4097   Not sure why you're asking me, but the gman3 09/25/12 09:29:34 AM
#4096   bottom line what really changed in the buy [SMART MONEY] 09/25/12 07:24:08 AM
#4095   If no want to sell: automatic buyer is swampboots 09/24/12 02:15:42 PM
#4094   What happens if you don't sell? I am lostinvestor 09/21/12 12:23:02 AM
#4093   So much for the short squeeze pushing this higher. FUNMAN818 09/18/12 08:17:04 PM
#4092   Hold Leverage: Rickety 09/13/12 06:29:49 PM
#4091   Actually you can get that definition from a UnallowedExistence 09/09/12 03:49:45 PM
#4090   When I wrote this UnallowedExistence 09/09/12 02:49:45 PM
#4089   Define fake. junkHustler 09/09/12 02:44:24 PM
#4088   I forgot and gave the wrong date there.It UnallowedExistence 09/09/12 01:56:48 PM
#4087   The short squeeze and this board seem to FUNMAN818 09/07/12 11:05:48 AM
#4086   Some notes might need to be added here UnallowedExistence 09/05/12 05:04:34 PM
#4085   Did anyone miss the amazing performance we saw here???????? UnallowedExistence 09/04/12 03:22:06 PM
#4084   I do not understand how the total cash UnallowedExistence 08/31/12 03:18:12 PM
#4083   Details of merger offer are on the SEC gman3 08/27/12 10:51:47 AM
#4082   novice-my opinion only. 20 million is pocket lint diarch 08/14/12 11:51:47 PM
#4081   diarch..do you think there's even a slight chance novicetrader 08/14/12 09:57:49 PM
#4080   ssc-yes, the quarter should be buried. Back-handed benefit: diarch 08/14/12 05:26:56 PM
#4079   As usual the market presents yet another interesting ssc 08/14/12 03:58:44 PM
#4078   Hi diarch, suit will probably disclose any funny carlos7 08/14/12 03:41:07 PM
#4077   carlos-exactly as I did. Sold half. Half on diarch 08/14/12 03:33:54 PM
#4076   after the fact yes but cnmd started down carlos7 08/14/12 03:30:12 PM
#4075   they dont like it YES and vkng having kimble1 08/14/12 03:26:58 PM
#4074   sold half vkng this am, will play out carlos7 08/14/12 03:26:32 PM
#4073   vkng's Q has nothing to do w/cnmd, suppect carlos7 08/14/12 03:24:33 PM
#4072   i would think so ....VKNG quarter was no bueno kimble1 08/14/12 03:21:26 PM
#4071   Looks like cnmd is taking a hit... carlos7 08/14/12 03:15:32 PM
#4070   It now looks like dueling lawsuits! Play4keeps2 08/14/12 03:03:46 PM
#4069   That didn't take too long... This can't gman3 08/14/12 01:31:55 PM
#4068   SHAREHOLDER ALERT: Law Firm of Levi & Korsinsky, junkHustler 08/14/12 01:27:08 PM
#4067   http://www.marketwatch.com/story/shareholder-alert-law-firm-of-levi-korsinsky-ll carlos7 08/14/12 01:19:48 PM
#4066   one of two things happen kimble1 08/14/12 12:41:08 PM
#4065   I would have liked a better offer and FUNMAN818 08/14/12 12:31:04 PM
#4064   Sorry for my innocence on these matters, but Rowdig 08/14/12 10:48:05 AM
#4063   Everything ties back to Bard... From CONMED's History: gman3 08/14/12 10:18:14 AM
#4062   It does seem to be a fairly small gman3 08/14/12 09:47:22 AM
#4061   The more you look at the numbers, the ssc 08/14/12 09:19:10 AM
#4060   agree completely RogueBravo 08/14/12 08:58:25 AM
#4059   As you form your opinion of the deal, ssc 08/14/12 08:42:18 AM
#4058   Interesting turn of events. I wasn't expecting gman3 08/14/12 08:05:08 AM
#4057   CONMED Corporation to Acquire Viking Systems, Inc. SmallCapsMarket 08/14/12 07:06:47 AM
#4056   I would tend to agree and hope it's gman3 08/13/12 12:33:29 PM
#4055   We're all looking forward to learning what's happening. FUNMAN818 08/13/12 11:00:31 AM
PostSubject